- Home
- SLDB vs EVGO Comparison
SLDB vs EVGO Comparison
Compare SLDB & EVGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLDB
- EVGO
- Stock Information
- Founded
- SLDB 2013
- EVGO 2010
- Country
- SLDB United States
- EVGO United States
- Employees
- SLDB N/A
- EVGO N/A
- Industry
- SLDB Biotechnology: Biological Products (No Diagnostic Substances)
- EVGO Other Specialty Stores
- Sector
- SLDB Health Care
- EVGO Consumer Discretionary
- Exchange
- SLDB Nasdaq
- EVGO Nasdaq
- Market Cap
- SLDB 529.4M
- EVGO 462.9M
- IPO Year
- SLDB 2018
- EVGO N/A
- Fundamental
- Price
- SLDB $6.11
- EVGO $3.81
- Analyst Decision
- SLDB Strong Buy
- EVGO Buy
- Analyst Count
- SLDB 10
- EVGO 9
- Target Price
- SLDB $15.00
- EVGO $6.19
- AVG Volume (30 Days)
- SLDB 1.4M
- EVGO 4.9M
- Earning Date
- SLDB 08-12-2025
- EVGO 08-05-2025
- Dividend Yield
- SLDB N/A
- EVGO N/A
- EPS Growth
- SLDB N/A
- EVGO N/A
- EPS
- SLDB N/A
- EVGO N/A
- Revenue
- SLDB N/A
- EVGO $308,365,000.00
- Revenue This Year
- SLDB N/A
- EVGO $40.85
- Revenue Next Year
- SLDB N/A
- EVGO $32.54
- P/E Ratio
- SLDB N/A
- EVGO N/A
- Revenue Growth
- SLDB N/A
- EVGO 49.06
- 52 Week Low
- SLDB $2.41
- EVGO $2.20
- 52 Week High
- SLDB $10.37
- EVGO $9.07
- Technical
- Relative Strength Index (RSI)
- SLDB 49.25
- EVGO 55.80
- Support Level
- SLDB $5.87
- EVGO $3.68
- Resistance Level
- SLDB $6.81
- EVGO $4.10
- Average True Range (ATR)
- SLDB 0.46
- EVGO 0.25
- MACD
- SLDB -0.14
- EVGO 0.04
- Stochastic Oscillator
- SLDB 22.22
- EVGO 60.49
About SLDB Solid Biosciences Inc.
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.
About EVGO EVgo Inc.
EVgo owns and operates a public direct current fast-charging network in the US. Its network of charging stations provides electric vehicle charging infrastructure to consumers and businesses. The network is capable of charging all EV models and meets all charging standards currently available in the US. EVgo partners with national and regional chains of grocery stores, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners to locate and deploy its EV charging infrastructure.